MetaMax Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
20
- Latest Deal Type
-
Out of Business
MetaMax General Information
Description
Provider of bio-pharmaceutical drugs designed to treat oncology and metabolic diseases. The company's drugs are used to provide treatment for malignant tumors, including glioblastoma, pancreatic cancer, gastrointestinal cancers, melanoma, bladder and liver cancer, enabling healthcare providers to cure their cancer patients.
Contact Information
Website
www.metamax.bizCorporate Office
- Building 1, 12/19
- Verkhnaya Radishchevskaya Street
- Moscow, 109240
- Russia
Corporate Office
- Building 1, 12/19
- Verkhnaya Radishchevskaya Street
- Moscow, 109240
- Russia
MetaMax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 31-Dec-2025 | Completed | Out of Business | |||
| 1. Early Stage VC | 21-Aug-2013 | Completed | Clinical Trials - Phase 1 |
MetaMax Signals
MetaMax FAQs
-
When was MetaMax founded?
MetaMax was founded in 2010.
-
Where is MetaMax headquartered?
MetaMax is headquartered in Moscow, Russia.
-
What is the size of MetaMax?
MetaMax has 20 total employees.
-
What industry is MetaMax in?
MetaMax’s primary industry is Drug Discovery.
-
Is MetaMax a private or public company?
MetaMax is a Private company.
-
What is MetaMax’s current revenue?
The current revenue for MetaMax is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process